| mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
0.16 |
8e-05 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
8e-05 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.0004 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
| mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.001 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
| mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
0.14 |
0.002 |